The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Human Platelet Lysate-Global Market Insights and Sales Trends 2025
Synopsis
Human platelet lysate (HPL) is a non-animal derived cell culture growth supplement obtained from blood platelets after freezing and thawing. HPL contains abundant growth factors and cytokines necessary for cell growth and proliferation. Platelet lysate can be used as a source of growth factors to replace bovine serum in cell culture medium. Replacing bovine serum with HPL allows expansion and clinical grade production of functional mesenchymal stromal cells by removing the risk of xenogeneic immune reactions and transmission of bovine prion and viral pathogens.
The global Human Platelet Lysate market size is expected to reach US$ 2913.3 million by 2029, growing at a CAGR of 2.1% from 2023 to 2029. The market is mainly driven by the significant applications of Human Platelet Lysate in various end use industries. The expanding demands from the Contract Research Organizations, Academic & Research Institutes, Pharmaceutical Companies and Others, are propelling Human Platelet Lysate market. Heparin, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Heparin Free segment is estimated at % CAGR for the next seven-year period.
The global market for medical devices is estimated at US$ 603 billion in the year 2023, and will be growing at a CAGR of 5% during next six years. The global healthcare spending contributes to occupy 10% of the global GDP and is continuously rising in recent years due to the increasing health needs of the aging population, the growing prevalence of chronic and infectious diseases and the expansion of emerging markets. The medical devices market plays a significant role in the healthcare industry. The market is driven by several factors, including the increasing demand for advanced healthcare services globally, advancements in medical technology, growing geriatric population, rising healthcare expenditure, and increasing awareness about early disease diagnosis and treatment.
Report Objectives
This report provides market insight on the different segments, by manufacturers, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Human Platelet Lysate, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Human Platelet Lysate market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Human Platelet Lysate market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Human Platelet Lysate sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Human Platelet Lysate covered in this report include Mill Creek Life Sciences, Merck & Co., Inc, STEMCELL Technologies Inc, AventaCell BioMedical, Compass Biomedical, Inc, Macopharma SA, Trinova Biochem GmbH, PL BioScience GmbH and Cook Regentec, etc.
The global Human Platelet Lysate market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
Mill Creek Life Sciences
Merck & Co., Inc
STEMCELL Technologies Inc
AventaCell BioMedical
Compass Biomedical, Inc
Macopharma SA
Trinova Biochem GmbH
PL BioScience GmbH
Cook Regentec
Global Human Platelet Lysate market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Human Platelet Lysate market, Segment by Type:
Heparin
Heparin Free
Global Human Platelet Lysate market, by Application
Contract Research Organizations
Academic & Research Institutes
Pharmaceutical Companies
Others
Core Chapters
Chapter One: Introduces the study scope of this report, executive summary of market segments by Type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter Two: Detailed analysis of Human Platelet Lysate manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Three: Sales, revenue of Human Platelet Lysate in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.
Chapter Four: Introduces market segments by Application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter Five, Six, Seven, Eight and Nine: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.
Chapter Ten: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter Eleven: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics. Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Analysis of sales channel, distributors and customers.
Chapter Thirteen: Research Findings and Conclusion.
Human platelet lysate (HPL) is a non-animal derived cell culture growth supplement obtained from blood platelets after freezing and thawing. HPL contains abundant growth factors and cytokines necessary for cell growth and proliferation. Platelet lysate can be used as a source of growth factors to replace bovine serum in cell culture medium. Replacing bovine serum with HPL allows expansion and clinical grade production of functional mesenchymal stromal cells by removing the risk of xenogeneic immune reactions and transmission of bovine prion and viral pathogens.
The global Human Platelet Lysate market size is expected to reach US$ 2913.3 million by 2029, growing at a CAGR of 2.1% from 2023 to 2029. The market is mainly driven by the significant applications of Human Platelet Lysate in various end use industries. The expanding demands from the Contract Research Organizations, Academic & Research Institutes, Pharmaceutical Companies and Others, are propelling Human Platelet Lysate market. Heparin, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Heparin Free segment is estimated at % CAGR for the next seven-year period.
The global market for medical devices is estimated at US$ 603 billion in the year 2023, and will be growing at a CAGR of 5% during next six years. The global healthcare spending contributes to occupy 10% of the global GDP and is continuously rising in recent years due to the increasing health needs of the aging population, the growing prevalence of chronic and infectious diseases and the expansion of emerging markets. The medical devices market plays a significant role in the healthcare industry. The market is driven by several factors, including the increasing demand for advanced healthcare services globally, advancements in medical technology, growing geriatric population, rising healthcare expenditure, and increasing awareness about early disease diagnosis and treatment.
Report Objectives
This report provides market insight on the different segments, by manufacturers, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Human Platelet Lysate, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Human Platelet Lysate market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Human Platelet Lysate market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Human Platelet Lysate sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Human Platelet Lysate covered in this report include Mill Creek Life Sciences, Merck & Co., Inc, STEMCELL Technologies Inc, AventaCell BioMedical, Compass Biomedical, Inc, Macopharma SA, Trinova Biochem GmbH, PL BioScience GmbH and Cook Regentec, etc.
The global Human Platelet Lysate market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
Mill Creek Life Sciences
Merck & Co., Inc
STEMCELL Technologies Inc
AventaCell BioMedical
Compass Biomedical, Inc
Macopharma SA
Trinova Biochem GmbH
PL BioScience GmbH
Cook Regentec
Global Human Platelet Lysate market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Human Platelet Lysate market, Segment by Type:
Heparin
Heparin Free
Global Human Platelet Lysate market, by Application
Contract Research Organizations
Academic & Research Institutes
Pharmaceutical Companies
Others
Core Chapters
Chapter One: Introduces the study scope of this report, executive summary of market segments by Type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter Two: Detailed analysis of Human Platelet Lysate manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Three: Sales, revenue of Human Platelet Lysate in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.
Chapter Four: Introduces market segments by Application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter Five, Six, Seven, Eight and Nine: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.
Chapter Ten: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter Eleven: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics. Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Analysis of sales channel, distributors and customers.
Chapter Thirteen: Research Findings and Conclusion.
Index1 Human Platelet Lysate Market Overview
1.1 Human Platelet Lysate Product Overview
1.2 Human Platelet Lysate Market Segment by Type
1.2.1 Heparin
1.2.2 Heparin Free
1.3 Global Human Platelet Lysate Market Size by Type
1.3.1 Global Human Platelet Lysate Market Size Overview by Type (2018-2029)
1.3.2 Global Human Platelet Lysate Historic Market Size Review by Type (2018-2023)
1.3.3 Global Human Platelet Lysate Forecasted Market Size by Type (2024-2029)
1.4 Key Regions Market Size Segment by Type
1.4.1 North America Human Platelet Lysate Sales Breakdown by Type (2018-2023)
1.4.2 Europe Human Platelet Lysate Sales Breakdown by Type (2018-2023)
1.4.3 Asia-Pacific Human Platelet Lysate Sales Breakdown by Type (2018-2023)
1.4.4 Latin America Human Platelet Lysate Sales Breakdown by Type (2018-2023)
1.4.5 Middle East and Africa Human Platelet Lysate Sales Breakdown by Type (2018-2023)
2 Global Human Platelet Lysate Market Competition by Company
2.1 Global Top Players by Human Platelet Lysate Sales (2018-2023)
2.2 Global Top Players by Human Platelet Lysate Revenue (2018-2023)
2.3 Global Top Players by Human Platelet Lysate Price (2018-2023)
2.4 Global Top Manufacturers Human Platelet Lysate Manufacturing Base Distribution, Sales Area, Product Type
2.5 Human Platelet Lysate Market Competitive Situation and Trends
2.5.1 Human Platelet Lysate Market Concentration Rate (2018-2023)
2.5.2 Global 5 and 10 Largest Manufacturers by Human Platelet Lysate Sales and Revenue in 2022
2.6 Global Top Manufacturers by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Human Platelet Lysate as of 2022)
2.7 Date of Key Manufacturers Enter into Human Platelet Lysate Market
2.8 Key Manufacturers Human Platelet Lysate Product Offered
2.9 Mergers & Acquisitions, Expansion
3 Human Platelet Lysate Status and Outlook by Region
3.1 Global Human Platelet Lysate Market Size and CAGR by Region: 2018 VS 2022 VS 2029
3.2 Global Human Platelet Lysate Historic Market Size by Region
3.2.1 Global Human Platelet Lysate Sales in Volume by Region (2018-2023)
3.2.2 Global Human Platelet Lysate Sales in Value by Region (2018-2023)
3.2.3 Global Human Platelet Lysate Sales (Volume & Value) Price and Gross Margin (2018-2023)
3.3 Global Human Platelet Lysate Forecasted Market Size by Region
3.3.1 Global Human Platelet Lysate Sales in Volume by Region (2024-2029)
3.3.2 Global Human Platelet Lysate Sales in Value by Region (2024-2029)
3.3.3 Global Human Platelet Lysate Sales (Volume & Value), Price and Gross Margin (2024-2029)
4 Global Human Platelet Lysate by Application
4.1 Human Platelet Lysate Market Segment by Application
4.1.1 Contract Research Organizations
4.1.2 Academic & Research Institutes
4.1.3 Pharmaceutical Companies
4.1.4 Others
4.2 Global Human Platelet Lysate Market Size by Application
4.2.1 Global Human Platelet Lysate Market Size Overview by Application (2018-2029)
4.2.2 Global Human Platelet Lysate Historic Market Size Review by Application (2018-2023)
4.2.3 Global Human Platelet Lysate Forecasted Market Size by Application (2024-2029)
4.3 Key Regions Market Size Segment by Application
4.3.1 North America Human Platelet Lysate Sales Breakdown by Application (2018-2023)
4.3.2 Europe Human Platelet Lysate Sales Breakdown by Application (2018-2023)
4.3.3 Asia-Pacific Human Platelet Lysate Sales Breakdown by Application (2018-2023)
4.3.4 Latin America Human Platelet Lysate Sales Breakdown by Application (2018-2023)
4.3.5 Middle East and Africa Human Platelet Lysate Sales Breakdown by Application (2018-2023)
5 North America Human Platelet Lysate by Country
5.1 North America Human Platelet Lysate Historic Market Size by Country
5.1.1 North America Human Platelet Lysate Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
5.1.2 North America Human Platelet Lysate Sales in Volume by Country (2018-2023)
5.1.3 North America Human Platelet Lysate Sales in Value by Country (2018-2023)
5.2 North America Human Platelet Lysate Forecasted Market Size by Country
5.2.1 North America Human Platelet Lysate Sales in Volume by Country (2024-2029)
5.2.2 North America Human Platelet Lysate Sales in Value by Country (2024-2029)
6 Europe Human Platelet Lysate by Country
6.1 Europe Human Platelet Lysate Historic Market Size by Country
6.1.1 Europe Human Platelet Lysate Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
6.1.2 Europe Human Platelet Lysate Sales in Volume by Country (2018-2023)
6.1.3 Europe Human Platelet Lysate Sales in Value by Country (2018-2023)
6.2 Europe Human Platelet Lysate Forecasted Market Size by Country
6.2.1 Europe Human Platelet Lysate Sales in Volume by Country (2024-2029)
6.2.2 Europe Human Platelet Lysate Sales in Value by Country (2024-2029)
7 Asia-Pacific Human Platelet Lysate by Region
7.1 Asia-Pacific Human Platelet Lysate Historic Market Size by Region
7.1.1 Asia-Pacific Human Platelet Lysate Market Size Growth Rate (CAGR) by Region: 2018 VS 2022 VS 2029
7.1.2 Asia-Pacific Human Platelet Lysate Sales in Volume by Region (2018-2023)
7.1.3 Asia-Pacific Human Platelet Lysate Sales in Value by Region (2018-2023)
7.2 Asia-Pacific Human Platelet Lysate Forecasted Market Size by Region
7.2.1 Asia-Pacific Human Platelet Lysate Sales in Volume by Region (2024-2029)
7.2.2 Asia-Pacific Human Platelet Lysate Sales in Value by Region (2024-2029)
8 Latin America Human Platelet Lysate by Country
8.1 Latin America Human Platelet Lysate Historic Market Size by Country
8.1.1 Latin America Human Platelet Lysate Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
8.1.2 Latin America Human Platelet Lysate Sales in Volume by Country (2018-2023)
8.1.3 Latin America Human Platelet Lysate Sales in Value by Country (2018-2023)
8.2 Latin America Human Platelet Lysate Forecasted Market Size by Country
8.2.1 Latin America Human Platelet Lysate Sales in Volume by Country (2024-2029)
8.2.2 Latin America Human Platelet Lysate Sales in Value by Country (2024-2029)
9 Middle East and Africa Human Platelet Lysate by Country
9.1 Middle East and Africa Human Platelet Lysate Historic Market Size by Country
9.1.1 Middle East and Africa Human Platelet Lysate Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
9.1.2 Middle East and Africa Human Platelet Lysate Sales in Volume by Country (2018-2023)
9.1.3 Middle East and Africa Human Platelet Lysate Sales in Value by Country (2018-2023)
9.2 Middle East and Africa Human Platelet Lysate Forecasted Market Size by Country
9.2.1 Middle East and Africa Human Platelet Lysate Sales in Volume by Country (2024-2029)
9.2.2 Middle East and Africa Human Platelet Lysate Sales in Value by Country (2024-2029)
10 Company Profiles
10.1 Mill Creek Life Sciences
10.1.1 Mill Creek Life Sciences Company Information
10.1.2 Mill Creek Life Sciences Introduction and Business Overview
10.1.3 Mill Creek Life Sciences Human Platelet Lysate Sales, Revenue and Gross Margin (2018-2023)
10.1.4 Mill Creek Life Sciences Human Platelet Lysate Products Offered
10.1.5 Mill Creek Life Sciences Recent Development
10.2 Merck & Co., Inc
10.2.1 Merck & Co., Inc Company Information
10.2.2 Merck & Co., Inc Introduction and Business Overview
10.2.3 Merck & Co., Inc Human Platelet Lysate Sales, Revenue and Gross Margin (2018-2023)
10.2.4 Merck & Co., Inc Human Platelet Lysate Products Offered
10.2.5 Merck & Co., Inc Recent Development
10.3 STEMCELL Technologies Inc
10.3.1 STEMCELL Technologies Inc Company Information
10.3.2 STEMCELL Technologies Inc Introduction and Business Overview
10.3.3 STEMCELL Technologies Inc Human Platelet Lysate Sales, Revenue and Gross Margin (2018-2023)
10.3.4 STEMCELL Technologies Inc Human Platelet Lysate Products Offered
10.3.5 STEMCELL Technologies Inc Recent Development
10.4 AventaCell BioMedical
10.4.1 AventaCell BioMedical Company Information
10.4.2 AventaCell BioMedical Introduction and Business Overview
10.4.3 AventaCell BioMedical Human Platelet Lysate Sales, Revenue and Gross Margin (2018-2023)
10.4.4 AventaCell BioMedical Human Platelet Lysate Products Offered
10.4.5 AventaCell BioMedical Recent Development
10.5 Compass Biomedical, Inc
10.5.1 Compass Biomedical, Inc Company Information
10.5.2 Compass Biomedical, Inc Introduction and Business Overview
10.5.3 Compass Biomedical, Inc Human Platelet Lysate Sales, Revenue and Gross Margin (2018-2023)
10.5.4 Compass Biomedical, Inc Human Platelet Lysate Products Offered
10.5.5 Compass Biomedical, Inc Recent Development
10.6 Macopharma SA
10.6.1 Macopharma SA Company Information
10.6.2 Macopharma SA Introduction and Business Overview
10.6.3 Macopharma SA Human Platelet Lysate Sales, Revenue and Gross Margin (2018-2023)
10.6.4 Macopharma SA Human Platelet Lysate Products Offered
10.6.5 Macopharma SA Recent Development
10.7 Trinova Biochem GmbH
10.7.1 Trinova Biochem GmbH Company Information
10.7.2 Trinova Biochem GmbH Introduction and Business Overview
10.7.3 Trinova Biochem GmbH Human Platelet Lysate Sales, Revenue and Gross Margin (2018-2023)
10.7.4 Trinova Biochem GmbH Human Platelet Lysate Products Offered
10.7.5 Trinova Biochem GmbH Recent Development
10.8 PL BioScience GmbH
10.8.1 PL BioScience GmbH Company Information
10.8.2 PL BioScience GmbH Introduction and Business Overview
10.8.3 PL BioScience GmbH Human Platelet Lysate Sales, Revenue and Gross Margin (2018-2023)
10.8.4 PL BioScience GmbH Human Platelet Lysate Products Offered
10.8.5 PL BioScience GmbH Recent Development
10.9 Cook Regentec
10.9.1 Cook Regentec Company Information
10.9.2 Cook Regentec Introduction and Business Overview
10.9.3 Cook Regentec Human Platelet Lysate Sales, Revenue and Gross Margin (2018-2023)
10.9.4 Cook Regentec Human Platelet Lysate Products Offered
10.9.5 Cook Regentec Recent Development
11 Upstream, Opportunities, Challenges, Risks and Influences Factors Analysis
11.1 Human Platelet Lysate Key Raw Materials
11.1.1 Key Raw Materials
11.1.2 Key Raw Materials Price
11.1.3 Raw Materials Key Suppliers
11.2 Manufacturing Cost Structure
11.2.1 Raw Materials
11.2.2 Labor Cost
11.2.3 Manufacturing Expenses
11.3 Human Platelet Lysate Industrial Chain Analysis
11.4 Human Platelet Lysate Market Dynamics
11.4.1 Human Platelet Lysate Industry Trends
11.4.2 Human Platelet Lysate Market Drivers
11.4.3 Human Platelet Lysate Market Challenges
11.4.4 Human Platelet Lysate Market Restraints
12 Market Strategy Analysis, Distributors
12.1 Sales Channel
12.2 Human Platelet Lysate Distributors
12.3 Human Platelet Lysate Downstream Customers
13 Research Findings and Conclusion
14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.2 Data Source
14.2 Author Details
14.3 Disclaimer
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
